S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Med-Tech Stock Set To Rally! (Ad)
Federal student loan payments are starting again. Here's what you need to know
Facing increasing pressure from customers, some miners are switching to renewable energy
Med-Tech Stock Set To Rally! (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
Med-Tech Stock Set To Rally! (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Donald Trump says he will be in courtroom for New York trial scrutinizing his business practices
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Med-Tech Stock Set To Rally! (Ad)
Federal student loan payments are starting again. Here's what you need to know
Facing increasing pressure from customers, some miners are switching to renewable energy
Med-Tech Stock Set To Rally! (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
Med-Tech Stock Set To Rally! (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Donald Trump says he will be in courtroom for New York trial scrutinizing his business practices
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Med-Tech Stock Set To Rally! (Ad)
Federal student loan payments are starting again. Here's what you need to know
Facing increasing pressure from customers, some miners are switching to renewable energy
Med-Tech Stock Set To Rally! (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
Med-Tech Stock Set To Rally! (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Donald Trump says he will be in courtroom for New York trial scrutinizing his business practices
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Med-Tech Stock Set To Rally! (Ad)
Federal student loan payments are starting again. Here's what you need to know
Facing increasing pressure from customers, some miners are switching to renewable energy
Med-Tech Stock Set To Rally! (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
Med-Tech Stock Set To Rally! (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Donald Trump says he will be in courtroom for New York trial scrutinizing his business practices

Nature's Sunshine Products (NATR) Stock Forecast, Price & News

$16.57
-0.12 (-0.72%)
(As of 09/29/2023 ET)
Compare
Today's Range
$16.53
$16.93
50-Day Range
$13.58
$16.92
52-Week Range
$7.93
$17.25
Volume
20,320 shs
Average Volume
63,273 shs
Market Capitalization
$316.49 million
P/E Ratio
63.73
Dividend Yield
N/A
Price Target
$19.50

Nature's Sunshine Products MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
17.7% Upside
$19.50 Price Target
Short Interest
Healthy
0.33% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.93mentions of Nature
Based on 2 Articles This Week
Insider Trading
Selling Shares
$200,690 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.37 out of 5 stars

Medical Sector

268th out of 970 stocks

Pharmaceutical Preparations Industry

104th out of 448 stocks


NATR stock logo

About Nature's Sunshine Products (NASDAQ:NATR) Stock

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.

NATR Price History

NATR Stock News Headlines

The Bio-Tech Stock That Needs Your Attention!
There a Few Opportunities Like This Stock! Sign Up Today And Get Our NExt Bio-Tech Alert!
Nature`s Sunshine Products, Inc.
The Bio-Tech Stock That Needs Your Attention!
There a Few Opportunities Like This Stock! Sign Up Today And Get Our NExt Bio-Tech Alert!
NATR Nature's Sunshine Products, Inc.
See More Headlines
Receive NATR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nature's Sunshine Products and its competitors with MarketBeat's FREE daily newsletter.

NATR Company Calendar

Last Earnings
8/09/2023
Today
10/01/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Personal Products
Sector
Medical
Current Symbol
NASDAQ:NATR
CUSIP
63902710
Employees
800
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$19.50
High Stock Price Forecast
$19.50
Low Stock Price Forecast
$19.50
Forecasted Upside/Downside
+17.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-390,000.00
Pretax Margin
3.83%

Debt

Sales & Book Value

Annual Sales
$421.91 million
Cash Flow
$0.67 per share
Book Value
$7.67 per share

Miscellaneous

Free Float
18,200,000
Market Cap
$316.49 million
Optionable
Not Optionable
Beta
0.87
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Terrence O. Moorehead (Age 60)
    Pres, CEO & Director
    Comp: $762.12k
  • Mr. L. Shane Jones (Age 52)
    Exec. VP, CFO & Treasurer
  • Mr. Martin Gonzalez (Age 54)
    Exec. VP of Global Supply Chain Operations
    Comp: $546.38k
  • Trent McCausland
    Exec. Director, Head of Operations & COO
  • Mr. Nathan G. Brower (Age 43)
    Exec. VP, Gen. Counsel & Sec.
  • Ms. Tracee Comstock (Age 57)
    VP of HR
  • Mr. Bryant J. Yates (Age 50)
    Exec. VP & Pres of Europe
  • Mr. Daniel C. Norman (Age 49)
    Exec. VP & Pres of Asia/Pacific (APAC)
  • Mr. Kevin R. Herbert
    Exec. VP & Pres of North America
  • Mr. Jonathan D. Lanoy (Age 47)
    Sr. VP of Fin. & Corp. Controller













NATR Stock - Frequently Asked Questions

Should I buy or sell Nature's Sunshine Products stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nature's Sunshine Products in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NATR shares.
View NATR analyst ratings
or view top-rated stocks.

What is Nature's Sunshine Products' stock price forecast for 2023?

1 brokers have issued 12-month price objectives for Nature's Sunshine Products' stock. Their NATR share price forecasts range from $19.50 to $19.50. On average, they anticipate the company's share price to reach $19.50 in the next twelve months. This suggests a possible upside of 17.7% from the stock's current price.
View analysts price targets for NATR
or view top-rated stocks among Wall Street analysts.

How have NATR shares performed in 2023?

Nature's Sunshine Products' stock was trading at $8.32 at the beginning of the year. Since then, NATR shares have increased by 99.2% and is now trading at $16.57.
View the best growth stocks for 2023 here
.

When is Nature's Sunshine Products' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our NATR earnings forecast
.

How were Nature's Sunshine Products' earnings last quarter?

Nature's Sunshine Products, Inc. (NASDAQ:NATR) issued its quarterly earnings data on Wednesday, August, 9th. The company reported $0.12 earnings per share (EPS) for the quarter. The business had revenue of $116.55 million for the quarter. Nature's Sunshine Products had a net margin of 1.23% and a trailing twelve-month return on equity of 5.42%.

What guidance has Nature's Sunshine Products issued on next quarter's earnings?

Nature's Sunshine Products issued an update on its FY 2023 earnings guidance on Thursday, August, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $440.00 million-$455.00 million, compared to the consensus revenue estimate of $431.48 million.

What is Terrence Moorehead's approval rating as Nature's Sunshine Products' CEO?

13 employees have rated Nature's Sunshine Products Chief Executive Officer Terrence Moorehead on Glassdoor.com. Terrence Moorehead has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Nature's Sunshine Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nature's Sunshine Products investors own include Amicus Therapeutics (FOLD), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Akorn (AKRX), Bausch Health Companies (BHC), Catalyst Pharmaceuticals (CPRX), Exelixis (EXEL) and Global Blood Therapeutics (GBT).

What is Nature's Sunshine Products' stock symbol?

Nature's Sunshine Products trades on the NASDAQ under the ticker symbol "NATR."

How do I buy shares of Nature's Sunshine Products?

Shares of NATR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nature's Sunshine Products' stock price today?

One share of NATR stock can currently be purchased for approximately $16.57.

How much money does Nature's Sunshine Products make?

Nature's Sunshine Products (NASDAQ:NATR) has a market capitalization of $316.49 million and generates $421.91 million in revenue each year. The company earns $-390,000.00 in net income (profit) each year or $0.26 on an earnings per share basis.

How many employees does Nature's Sunshine Products have?

The company employs 800 workers across the globe.

How can I contact Nature's Sunshine Products?

Nature's Sunshine Products' mailing address is 2901 WEST BLUEGRASS BOULEVARD SUITE 100, LEHI UT, 84043. The official website for the company is www.naturessunshine.com. The company can be reached via phone at (801) 341-7900, via email at investorrelations@natr.com, or via fax at 801-342-4305.

This page (NASDAQ:NATR) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -